Who owns OM?
Institutional ownership of Outset Medical Inc. from Form 13F, Q2 2026
93 institutional managers reported holding Outset Medical Inc. (OM) in Form 13F filings for Q2 2026, with 14,187,003 shares worth $61.3M. The largest reported holder was FMR LLC. Managers that filed both quarters cut a net 572,711 shares (-3.9%). 20 opened new positions and 22 sold out.
- Funds holding
- 93
- Value held
- $61.3M
- New / sold out
- 20 / 22
- Net shares, same filers
- -3.9%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of OM
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| FMR LLC | $11.8M | 19.3% | 2,742,887 | Unchanged |
| BML Capital Management, LLC | $10.9M | 17.8% | 2,519,701 | Added |
| AQR Capital Management LLC | $4.3M | 7.0% | 998,961 | Added |
| Perceptive Advisors LLC | $3.6M | 5.9% | 833,333 | Unchanged |
| Vanguard Capital Management LLC | $3.4M | 5.5% | 780,134 | Added |
| Assenagon Asset Management S.A. | $2.9M | 4.8% | 678,876 | Added |
| Bank of America Corp | $2.9M | 4.7% | 665,847 | Trimmed |
| PFM Health Sciences, LP | $2.5M | 4.1% | 582,122 | Trimmed |
| Ensign Peak Advisors, Inc | $1.9M | 3.1% | 434,341 | Trimmed |
| BlackRock, Inc. | $1.8M | 2.9% | 418,211 | Trimmed |
| Peapod Lane Capital LLC | $1.4M | 2.3% | 331,951 | New |
| Marshall Wace, LLP | $916K | 1.5% | 211,993 | New |
| Geode Capital Management, LLC | $885K | 1.4% | 204,652 | Trimmed |
| Stratos Wealth Partners, LTD. | $866K | 1.4% | 200,546 | Unchanged |
| UBS Group AG | $822K | 1.3% | 190,289 | Trimmed |
| Morgan Stanley | $786K | 1.3% | 181,983 | Added |
| Millennium Management LLC | $785K | 1.3% | 181,794 | New |
| Goldman Sachs Group Inc | $749K | 1.2% | 173,460 | Added |
| Jane Street Group, LLC | $601K | 1.0% | 139,197 | Added |
| XTX Topco Ltd | $539K | 0.9% | 124,690 | Trimmed |
| Catalio Capital Management, LP | $511K | 0.8% | 118,279 | Unchanged |
| Vanguard Fiduciary Trust Co | $496K | 0.8% | 114,912 | Added |
| GMT Capital Corp | $424K | 0.7% | 98,108 | Added |
| Dimensional Fund Advisors LP | $392K | 0.6% | 90,698 | Trimmed |
| Pura Vida Investments, LLC | $360K | 0.6% | 83,333 | Unchanged |
Share of 13F holdings is each fund's shares as a share of the 14,187,003 OM shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BML Capital Management, LLC Added+$2.7M
- Peapod Lane Capital LLC New+$1.4M
- Marshall Wace, LLP New+$916K
- AQR Capital Management LLC Added+$824K
- Millennium Management LLC New+$785K
- Assenagon Asset Management S.A. Added+$755K
- Goldman Sachs Group Inc Added+$346K
- Jane Street Group, LLC Added+$321K
- GMT Capital Corp Added+$241K
- Susquehanna International Group, LLP Added+$230K
Biggest sellers in Q2 2026
- BlackRock, Inc. Trimmed-$3.7M
- Bank of America Corp Trimmed-$1.2M
- Woodline Partners LP Sold out-$1.1M
- State Street Corp Trimmed-$1.1M
- Geode Capital Management, LLC Trimmed-$937K
- Renaissance Technologies LLC Trimmed-$772K
- JPMorgan Chase & Co Trimmed-$431K
- Ensign Peak Advisors, Inc Trimmed-$398K
- Vanguard Portfolio Management LLC Sold out-$379K
- Northern Trust Corp Trimmed-$354K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $10.2M and sold $12.4M; 31 added and 26 trimmed.
Schedule 13D and 13G filings on OM
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-08-12AQR CAPITAL MANAGEMENT LLC SCHEDULE 13G filed by Outset Medical Inc.Schedule 13G
- 2026-02-11BANK OF AMERICA CORP /DE/ SCHEDULE 13G filed by Outset Medical Inc.Schedule 13G
- 2026-01-14BML Investment Partners, L.P. SCHEDULE 13G filed by Outset Medical Inc.Schedule 13G
- 2025-07-29VANGUARD GROUP INC SCHEDULE 13G filed by Outset Medical Inc.Schedule 13G
- 2025-07-18BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-05-15Alyeska Investment Group, L.P. SCHEDULE 13G filed by Outset Medical Inc.Schedule 13G
- 2025-03-17PFM Health Sciences, LP SCHEDULE 13G filed by Outset Medical Inc.Schedule 13G
- 2025-03-01PERCEPTIVE ADVISORS LLC SCHEDULE 13G filed by Outset Medical Inc.Schedule 13G
Questions about OM ownership
- Who owns OM stock?
- 93 institutional investment managers reported OM positions in their Form 13F filings for Q2 2026, holding 14,187,003 shares worth $61.3M in total. FMR LLC reported the largest position.
- Are funds buying or selling OM?
- In Q2 2026, 20 managers opened new OM positions, 31 added, 26 trimmed and 22 sold out. Managers that filed in both quarters sold a net 572,711 shares.
- How current is this OM institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to OM by CUSIP. Options are left out. OM news and filings · OM insider trades · Top funds